Выбор редакции
03 апреля, 00:31

The Health 202: Opioid company blames government for Native American crisis

McKesson says it flagged suspiciously large orders.

23 марта, 16:55

Is McKesson Corporation (MCK) a Suitable Value Stock Now?

Let's see if McKesson Corporation (MCK) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.

Выбор редакции
19 марта, 10:56

Why Is Allscripts (MDRX) Down 11.3% Since its Last Earnings Report?

Allscripts (MDRX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

07 марта, 17:40

Cerner-Centrus Health to Collaborate, HealtheIntent in Focus

HealtheIntent will provide Cerner (CERN) significant exposure to the ongoing AI trends in the medical world.

Выбор редакции
27 февраля, 17:49

Allscripts' (MDRX) Fundamentals Strong Amid Stiff Competition

Allscripts' (MDRX) promising fourth-quarter results and international hold are encouraging. Integration risks and cutthroat competition are likely to mar prospects.

Выбор редакции
16 февраля, 16:22

Allscripts (MDRX) Q4 Earnings Meet, Revenues Beat Estimates

Solid year-over-year growth in Client Services revenues drove Allscripts in Q4.

13 февраля, 19:19

Cramer says the Bezos-Buffett-Dimon venture looks to cut ...

CNBC's Jim Cramer said Tuesday, according to sources, that Bezos' Amazon, Buffett's Berkshire Hathaway, and Dimon's J.P. Morgan aim to cut out drug distributors like Amerisource, Cardinal Health, and McKesson.

Выбор редакции
Выбор редакции
05 февраля, 17:05

The Zacks Analyst Blog Highlights: Lockheed Martin, Mastercard, Colgate, Electronic Arts and McKesson

The Zacks Analyst Blog Highlights: Lockheed Martin, Mastercard, Colgate, Electronic Arts and McKesson

02 февраля, 22:28

Top Stock Reports for Lockheed Martin, Mastercard & Colgate

Top Stock Reports for Lockheed Martin, Mastercard & Colgate

01 февраля, 22:39

McKesson (MCK) Beats on Q3 Earnings & Revenues, Ups '18 View

Strong Performance in Distribution Solutions segment drives McKesson (MCK) in Q3. An impressive FY18 outlook instills investor's optimism.

Выбор редакции
01 февраля, 16:30

McKesson (MCK) Beats on Earnings and Sales in Q3

McKesson Corporation (MCK) delivers strong performance on the back of solid organic growth.

Выбор редакции
01 февраля, 15:12

McKesson shares rise 0.7% pre-market

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news.

Выбор редакции
01 февраля, 15:11

McKesson expects 2018 adj. EPS of $12.50 to $12.80; FactSet consensus $12.26

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news.

31 января, 18:24

Medical Device Stocks Earnings Due on Feb 1: BSX, BAX & More

As part of the amended tax policy, corporate tax rates are lowered to 21% from 35%, offering a huge relief to medical device giants.

29 января, 17:05

Will Higher System Sales Drive Cerner's (CERN) Q4 Earnings?

Cerner (CERN) expects solid Q4 revenues on a surge in bookings. Stiff competition remains a concern.

25 января, 16:00

Mckesson (MCK) to Report Q3 Earnings: A Beat in the Cards?

McKesson's (MCK) Specialty Health unit is likely to drive the company's top line in the third quarter of fiscal 2018.